K. Roth, H. Koo, S. Spottswood, and J. Chan, Obstructive Uropathy: An Important Cause of Chronic Renal Failure in Children, Clinical Pediatrics, vol.34, issue.5, pp.309-314, 2002.
DOI : 10.1177/000992280204100503

M. Benfield, R. Mcdonald, and S. Bartosh, Changing trends in pediatric transplantation: 2001 Annual Report of the North American Pediatric Renal Transplant Cooperative Study, Pediatric Transplantation, vol.51, issue.Suppl.
DOI : 10.1034/j.1399-3046.2003.00029.x

R. Chevalier, Molecular and cellular pathophysiology of obstructive nephropathy, Pediatric Nephrology, vol.13, issue.7, pp.612-619, 1999.
DOI : 10.1007/s004670050756

C. Peters, Animal models of fetal renal disease, Prenatal Diagnosis, vol.159, issue.11, pp.917-923, 2001.
DOI : 10.1002/pd.211

J. Favor, R. Sandulache, and A. Neuhauser-klaus, The mouse Pax21Neu mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney, Proceedings of the National Academy of Sciences, vol.122, issue.2, pp.13870-13875, 1996.
DOI : 10.1016/0092-8674(90)90385-R

H. Nishimura, E. Yerkes, and K. Hohenfellner, Role of the Angiotensin Type 2 Receptor Gene in Congenital Anomalies of the Kidney and Urinary Tract, CAKUT, of Mice and Men, Molecular Cell, vol.3, issue.1, pp.1-10, 1999.
DOI : 10.1016/S1097-2765(00)80169-0

J. Friedman, J. Hoyer, and B. Mccormick, Congenital unilateral hydronephrosis in the rat, Kidney International, vol.15, issue.5, pp.567-571, 1979.
DOI : 10.1038/ki.1979.72

C. Horton, . Jr, M. Davisson, and J. Jacobs, Congenital progressive hydronephrosis in mice: a new recessive mutation, J Urol, vol.140, pp.1310-1315, 1988.

A. Tarantal, V. Han, and K. Cochrum, Fetal rhesus monkey model of obstructive renal dysplasia, Kidney International, vol.59, issue.2, pp.446-456, 2001.
DOI : 10.1046/j.1523-1755.2001.059002446.x

R. Chevalier, B. Thornhill, and A. Chang, Unilateral ureteral obstruction in neonatal rats leads to renal insufficiency in adulthood, Kidney International, vol.58, issue.5, 1987.
DOI : 10.1111/j.1523-1755.2000.00371.x

R. Chevalier, B. Thornhill, and A. Chang, Recovery from release of ureteral obstruction in the rat: Relationship to nephrogenesis, Kidney International, vol.61, issue.6, pp.2033-2043, 2002.
DOI : 10.1046/j.1523-1755.2002.00359.x

S. Klahr and J. Morrissey, Obstructive nephropathy and renal fibrosis, American Journal of Physiology - Renal Physiology, vol.283, issue.5, pp.861-875, 2002.
DOI : 10.1152/ajprenal.00362.2001

H. Kaneto, J. Morrissey, and R. Mccracken, Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney, Kidney International, vol.45, issue.6, pp.1637-1647, 1994.
DOI : 10.1038/ki.1994.215

S. Ishidoya, J. Morrissey, and R. Mccracken, Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction, Kidney International, vol.47, issue.5, pp.1285-1294, 1995.
DOI : 10.1038/ki.1995.183

S. Klahr and J. Morrissey, Comparative study of ACE inhibitors and angiotensin II receptor antagonists in interstitial scarring, Kidney Int, vol.63, pp.111-114, 1997.

M. Nishida, H. Fujinaka, and T. Matsusaka, Absence of angiotensin II type 1 receptor in bone marrow???derived cells is detrimental in the evolution of renal fibrosis, Journal of Clinical Investigation, vol.110, issue.12, pp.1859-1868, 2002.
DOI : 10.1172/JCI200215045

A. Eddy, Plasminogen activator inhibitor-1 and the kidney, American Journal of Physiology - Renal Physiology, vol.283, issue.2, pp.209-220, 2002.
DOI : 10.1152/ajprenal.00032.2002

T. Oda, Y. Jung, and H. Kim, PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction, Kidney International, vol.60, issue.2, pp.587-596, 2001.
DOI : 10.1046/j.1523-1755.2001.030002587.x

J. Yang, R. Shultz, and W. Mars, Disruption of tissue-type plasminogen activator gene in mice reduces renal interstitial fibrosis in obstructive nephropathy, Journal of Clinical Investigation, vol.110, issue.10, pp.1525-1538, 2002.
DOI : 10.1172/JCI0216219

Y. Miyazaki, S. Tsuchida, and H. Nishimura, Angiotensin induces the urinary peristaltic machinery during the perinatal period., Journal of Clinical Investigation, vol.102, issue.8, pp.1489-1497, 1998.
DOI : 10.1172/JCI4401

G. Schreiner and E. Unanue, Origin of the rat mesangial phagocyte and its expression of the leukocyte common antigen, Lab Invest, vol.51, pp.515-523, 1984.

V. Vielhauer, H. Anders, and M. Mack, Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2-and 5-positive leukocytes, J Am Soc Nephrol, vol.12, pp.1173-1187, 2001.

J. Diamond, D. Kees-folts, and S. Ricardo, Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis, Am J Pathol, vol.146, pp.1455-1466, 1995.

S. Ricardo and J. Diamond, The role of macrophages and reactive oxygen species in experimental hydronephrosis, Semin Nephrol, vol.18, pp.612-621, 1998.

B. Lange-sperandio, F. Cachat, B. Thornhill, and R. Chevalier, Selectins mediate macrophage infiltration in obstructive nephropathy in newborn mice11See Editorial by Kipari and Hughes, p. 760., Kidney International, vol.61, issue.2, pp.516-524, 2002.
DOI : 10.1046/j.1523-1755.2002.00162.x

C. Giachelli, D. Lombardi, and R. Johnson, Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo, Am J Pathol, vol.152, pp.353-358, 1998.

V. Ophascharoensuk, C. Giachelli, and K. Gordon, Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis, Kidney International, vol.56, issue.2, pp.571-580, 1999.
DOI : 10.1046/j.1523-1755.1999.00580.x

G. Weber, S. Ashkar, M. Glimcher, and H. Cantor, Receptor-Ligand Interaction Between CD44 and Osteopontin (Eta-1), Science, vol.271, issue.5248, pp.509-512, 1996.
DOI : 10.1126/science.271.5248.509

K. Rouschop, M. Sewnath, and N. Claessen, CD44 Deficiency Increases Tubular Damage But Reduces Renal Fibrosis in Obstructive Nephropathy, Journal of the American Society of Nephrology, vol.15, issue.3, pp.674-686, 2004.
DOI : 10.1097/01.ASN.0000115703.30835.96

K. Shikata, Y. Suzuki, and J. Wada, L-selectin and its ligands mediate infiltration of mononuclear cells into kidney interstitium after ureteric obstruction, The Journal of Pathology, vol.271, issue.1, pp.93-99, 1999.
DOI : 10.1002/(SICI)1096-9896(199905)188:1<93::AID-PATH305>3.0.CO;2-#

D. Ogawa, K. Shikata, and K. Honke, Cerebroside Sulfotransferase Deficiency Ameliorates L-selectin-dependent Monocyte Infiltration in the Kidney after Ureteral Obstruction, Journal of Biological Chemistry, vol.279, issue.3, pp.2085-2090, 2004.
DOI : 10.1074/jbc.M305809200

H. Anders, V. Vielhauer, and D. Schlondorff, Chemokines and chemokine receptors are involved in the resolution or progression of renal disease, Kidney International, vol.63, issue.2, pp.401-415, 2003.
DOI : 10.1046/j.1523-1755.2003.00750.x

V. Eis, B. Luckow, and V. Vielhauer, Chemokine Receptor CCR1 But Not CCR5 Mediates Leukocyte Recruitment and Subsequent Renal Fibrosis after Unilateral Ureteral Obstruction, Journal of the American Society of Nephrology, vol.15, issue.2, pp.337-347, 2004.
DOI : 10.1097/01.ASN.0000111246.87175.32

J. Diamond, D. Kees-folts, and G. Ding, Macrophages, monocyte chemoattractant peptide- 1, and TGF-beta 1 in experimental hydronephrosis, Am J Physiol, vol.266, pp.926-933, 1994.

S. Shappell, L. Mendoza, and T. Gurpinar, Expression of Adhesion Molecules in Kidney with Experimental Chronic Obstructive Uropathy: The Pathogenic Role of ICAM-1 and VCAM-1, Nephron, vol.85, issue.2, pp.156-166, 2000.
DOI : 10.1159/000045649

G. Gobe and R. Axelsen, Genesis of renal tubular atrophy in experimental hydronephrosis in the rat. Role of apoptosis, Lab Invest, vol.56, pp.273-281, 1987.

C. Sherr and J. Roberts, Inhibitors of mammalian G1 cyclin-dependent kinases., Genes & Development, vol.9, issue.10, pp.1149-1163, 1995.
DOI : 10.1101/gad.9.10.1149

V. Ophascharoensuk, M. Fero, and J. Hughes, The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury, Nature Medicine, vol.21, issue.5, pp.575-580, 1998.
DOI : 10.1016/0009-8981(75)90033-9

J. Hughes, P. Brown, and S. Shankland, Cyclin kinase inhibitor p21CIP1/WAF1 limits interstitial cell proliferation following ureteric obstruction, Am J Physiol, vol.277, pp.948-956, 1999.

F. Cachat, B. Lange-sperandio, and A. Chang, Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss11See Editorial by Woolf, p. 761., Kidney International, vol.63, issue.2, pp.564-575, 2003.
DOI : 10.1046/j.1523-1755.2003.00775.x

L. Truong, G. Petrusevska, and G. Yang, Cell apoptosis and proliferation in experimental chronic obstructive uropathy, Kidney International, vol.50, issue.1, pp.200-207, 1996.
DOI : 10.1038/ki.1996.303

R. Chevalier, K. Chung, and C. Smith, Renal Apoptosis and Clusterin Following Ureteral Obstruction, The Journal of Urology, vol.156, pp.1474-1479, 1996.
DOI : 10.1097/00005392-199610000-00075

J. Morrissey, S. Ishidoya, R. Mccracken, and S. Klahr, Control of p53 and p21 (WAF1) expression during unilateral ureteral obstruction, Kidney Int, vol.57, pp.84-92, 1996.

E. Hickman, M. Moroni, and K. Helin, The role of p53 and pRB in apoptosis and cancer, Current Opinion in Genetics & Development, vol.12, issue.1, pp.60-66, 2002.
DOI : 10.1016/S0959-437X(01)00265-9

Y. Choi, L. Mendoza, and S. Rha, Role of p53-dependent activation of caspases in chronic obstructive uropathy: evidence from p53 null mutant mice, J Am Soc Nephrol, vol.12, pp.983-992, 2001.

Y. Liu, Epithelial to Mesenchymal Transition in Renal Fibrogenesis: Pathologic Significance, Molecular Mechanism, and Therapeutic Intervention, Journal of the American Society of Nephrology, vol.15, issue.1, pp.1-12, 2004.
DOI : 10.1097/01.ASN.0000106015.29070.E7

D. Prockop, Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues, Science, vol.276, issue.5309, pp.71-74, 1997.
DOI : 10.1126/science.276.5309.71

F. Strutz, H. Okada, and C. Lo, Identification and characterization of a fibroblast marker: FSP1, The Journal of Cell Biology, vol.130, issue.2, pp.393-405, 1995.
DOI : 10.1083/jcb.130.2.393

M. Iwano, D. Plieth, and T. Danoff, Evidence that fibroblasts derive from epithelium during tissue fibrosis, Journal of Clinical Investigation, vol.110, issue.3, pp.341-350, 2002.
DOI : 10.1172/JCI0215518

S. Yang, A. Woolf, F. Quinn, and P. Winyard, Deregulation of Renal Transforming Growth Factor-??1 after Experimental Short-Term Ureteric Obstruction in Fetal Sheep, The American Journal of Pathology, vol.159, issue.1, pp.109-117, 2001.
DOI : 10.1016/S0002-9440(10)61678-1

J. Yang and Y. Liu, Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy, American Journal of Physiology - Renal Physiology, vol.284, issue.2, pp.349-357, 2003.
DOI : 10.1152/ajprenal.00154.2002

M. Zeisberg, J. Hanai, and H. Sugimoto, BMP-7 counteracts TGF-??1???induced epithelial-to-mesenchymal transition and reverses chronic renal injury, Nature Medicine, vol.9, issue.7, pp.964-968, 2003.
DOI : 10.1038/nm888

A. Eddy, Molecular basis of renal fibrosis, Pediatric Nephrology, vol.15, issue.3-4, pp.290-301, 2000.
DOI : 10.1007/s004670000461

L. Liotta, R. Goldfarb, and R. Brundage, Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane

E. Mochan and T. Keler, Plasmin degradation of cartilage proteoglycan, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.800, issue.3, pp.312-315, 1984.
DOI : 10.1016/0304-4165(84)90412-4

A. Mackay, R. Corbitt, J. Hartzler, and U. Thorgeirsson, Basement membrane type IV collagen degradation: evidence for the involvement of a proteolytic cascade independent of metalloproteinases, Cancer Res, vol.50, pp.5997-6001, 1990.

H. Cs, S. Wilhelm, and A. Pentland, Tissue cooperation in a proteolytic cascade activating human interstitial collagenase, PNAS, vol.86, pp.2632-2636, 1989.

H. Nagase, J. Enghild, K. Suzuki, and G. Salvesen, Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate, Biochemistry, vol.29, issue.24, pp.5783-5789, 1990.
DOI : 10.1021/bi00476a020

I. Kazes, F. Delarue, and J. Hagege, Soluble latent membrane-type 1 matrix metalloprotease secreted by human mesangial cells is activated by urokinase, Kidney International, vol.54, issue.6, pp.1976-1984, 1998.
DOI : 10.1046/j.1523-1755.1998.00216.x

P. Mignatti, Extracellular matrix remodeling by metalloproteinases and plasminogen activators, Kidney Int, vol.49, pp.12-14, 1995.

J. Vassalli, A. Sappino, and D. Belin, The plasminogen activator/plasmin system., Journal of Clinical Investigation, vol.88, issue.4, pp.1067-1072, 1991.
DOI : 10.1172/JCI115405

A. Eddy, Plasminogen activator inhibitor-1 and the kidney, American Journal of Physiology - Renal Physiology, vol.283, issue.2, pp.209-220, 2002.
DOI : 10.1152/ajprenal.00032.2002

G. Zhang, H. Kim, and X. Cai, Urokinase Receptor Deficiency Accelerates Renal Fibrosis in Obstructive Nephropathy, Journal of the American Society of Nephrology, vol.14, issue.5, pp.1254-1271, 2003.
DOI : 10.1097/01.ASN.0000064292.37793.FB

L. Naldini, E. Vigna, and A. Bardelli, Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction, Journal of Biological Chemistry, vol.270, issue.2, pp.603-611, 1995.
DOI : 10.1074/jbc.270.2.603

A. Sharma, S. Mauer, Y. Kim, and A. Michael, Altered expression of matrix metalloproteinase-2, TIMP, and TIMP-2 in obstructive nephropathy, J Lab Clin Med, vol.125, pp.754-761, 1995.

E. Engelmyer, H. Van-goor, D. Edwards, and J. Diamond, Differential mRNA expression of renal cortical tissue inhibitor of metalloproteinase-1, -2, and -3 in experimental hydronephrosis, J Am Soc Nephrol, vol.5, pp.1675-1683, 1995.

H. Kim, T. Oda, and J. Lopez-guisa, TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy, J Am Soc Nephrol, vol.12, pp.736-748, 2001.

R. Carey and H. Siragy, Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation, Endocrine Reviews, vol.24, issue.3, pp.261-271, 2003.
DOI : 10.1210/er.2003-0001

W. Mcdougal, Pharmacologic preservation of renal mass and function in obstructive uropathy, J Urol, vol.128, pp.418-421, 1982.

W. Yarger, D. Schocken, and R. Harris, Obstructive nephropathy in the rat: possible roles for the renin-angiotensin system, prostaglandins, and thromboxanes in postobstructive renal function., Journal of Clinical Investigation, vol.65, issue.2, pp.400-412, 1980.
DOI : 10.1172/JCI109683

E. Kaschina and T. Unger, Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function, Blood Pressure, vol.12, issue.2, pp.70-88, 2003.
DOI : 10.1080/08037050310001057

R. Fern, C. Yesko, and B. Thornhill, Reduced angiotensinogen expression attenuates renal interstitial fibrosis in obstructive nephropathy in mice, Journal of Clinical Investigation, vol.103, issue.1, pp.39-46, 1999.
DOI : 10.1172/JCI4236

M. Satoh, N. Kashihara, and Y. Yamasaki, Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice, J Am Soc Nephrol, vol.12, pp.317-325, 2001.

J. Ma, H. Nishimura, and A. Fogo, Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction Rapid Communication, Kidney International, vol.53, issue.4, pp.937-944, 1998.
DOI : 10.1111/j.1523-1755.1998.00893.x

S. Klahr and J. Morrissey, Angiotensin II and gene expression in the kidney, American Journal of Kidney Diseases, vol.31, issue.1, pp.171-176, 1998.
DOI : 10.1053/ajkd.1998.v31.pm9428470

A. Brasier and J. Li, Mechanisms for Inducible Control of Angiotensinogen Gene Transcription, Hypertension, vol.27, issue.3, pp.465-475, 1996.
DOI : 10.1161/01.HYP.27.3.465

M. Schmitz and P. Baeuerle, Multi-Step Activation of NF-??B/Rel Transcription Factors, Immunobiology, vol.193, issue.2-4, pp.116-127, 1995.
DOI : 10.1016/S0171-2985(11)80534-6

G. Guo, J. Morrissey, and R. Mccracken, Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy, Am J Physiol, vol.277, pp.766-772, 1999.

D. Campbell, A. Kladis, and A. Duncan, Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides, Hypertension, vol.23, issue.4, pp.439-449, 1994.
DOI : 10.1161/01.HYP.23.4.439

J. Schanstra, E. Neau, and P. Drogoz, In vivo bradykinin B2 receptor activation reduces renal fibrosis, Journal of Clinical Investigation, vol.110, issue.3, pp.371-379, 2002.
DOI : 10.1172/JCI0215493

J. Schanstra, J. Duchene, and L. Desmond, The protective effect of angiotensin converting enzyme inhibition in experimental renal fibrosis in mice is not mediated by bradykinin B2 receptor activation, Thromb Haemost, vol.89, pp.735-740, 2003.

H. Okada, Y. Watanabe, and T. Kikuta, Bradykinin Decreases Plasminogen Activator Inhibitor-1 Expression and Facilitates Matrix Degradation in the Renal Tubulointerstitium under Angiotensin-Converting Enzyme Blockade, Journal of the American Society of Nephrology, vol.15, issue.9, pp.2404-2417, 2004.
DOI : 10.1097/01.ASN.0000136132.20189.95

J. Bascands and J. Schanstra, Bradykinin and Renal Fibrosis: Have We ACE'd it?, Journal of the American Society of Nephrology, vol.15, issue.9, pp.2504-2506, 2004.
DOI : 10.1097/01.ASN.0000143721.71748.30

S. El-dahr, J. Gee, and S. Dipp, Upregulation of renin-angiotensin system and downregulation of kallikrein in obstructive nephropathy, Am J Physiol, vol.264, pp.874-881, 1993.

K. Sharma and F. Ziyadeh, The emerging role of transforming growth factor-beta in kidney diseases, Am J Physiol, vol.266, issue.842, p.829, 1994.

H. Kaneto, H. Ohtani, and A. Fukuzaki, Increased expression of TGF-??1 but not of its receptors contributes to human obstructive nephropathy, Kidney International, vol.56, issue.6, pp.2137-2146, 1999.
DOI : 10.1046/j.1523-1755.1999.00790.x

M. Dickson, J. Martin, and F. Cousins, Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice, Development, vol.121, pp.1845-1854, 1995.

J. Massague and D. Wotton, NEW EMBO MEMBERS REVIEW: Transcriptional control by the TGF-beta/Smad signaling system, The EMBO Journal, vol.19, issue.8, pp.1745-1754, 2000.
DOI : 10.1093/emboj/19.8.1745

X. Yang, J. Letterio, and R. Lechleider, Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta, The EMBO Journal, vol.18, issue.5, pp.1280-1291, 1999.
DOI : 10.1093/emboj/18.5.1280

M. Sato, Y. Muragaki, and S. Saika, Targeted disruption of TGF-??1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction, Journal of Clinical Investigation, vol.112, issue.10, pp.1486-1494, 2003.
DOI : 10.1172/JCI200319270

L. Ma, H. Yang, and A. Gaspert, Transforming Growth Factor-??-Dependent and -Independent Pathways of Induction of Tubulointerstitial Fibrosis in ??6???/??? Mice, The American Journal of Pathology, vol.163, issue.4, pp.1261-1273, 2003.
DOI : 10.1016/S0002-9440(10)63486-4

L. Schaefer, K. Macakova, and I. Raslik, Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction, The American Journal of Pathology, vol.160, issue.3, pp.1181-1191, 2002.
DOI : 10.1016/S0002-9440(10)64937-1

A. Rodriguez-pena, N. Eleno, and A. Duwell, Endoglin Upregulation During Experimental Renal Interstitial Fibrosis in Mice, Hypertension, vol.40, issue.5, pp.713-720, 2002.
DOI : 10.1161/01.HYP.0000037429.73954.27

K. Edgtton, R. Gow, and D. Kelly, Plasmin is not protective in experimental renal interstitial fibrosis1, Kidney International, vol.66, issue.1, pp.68-76, 2004.
DOI : 10.1111/j.1523-1755.2004.00707.x

R. Kalluri and E. Neilson, Epithelial-mesenchymal transition and its implications for fibrosis, Journal of Clinical Investigation, vol.112, issue.12, pp.1776-1784, 2003.
DOI : 10.1172/JCI200320530